Dongsik Lim

Dr. Dongsik Lim

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JPJin-Woo Park
Jin-Woo Park
EKEun-Kyoung Kim
Eun-Kyoung Kim
DLDongsik Lim
Dongsik Lim
TOTak Kyu Oh
Tak Kyu Oh
SPSeongjoo Park
Seongjoo Park
SDSang-Hwan Do
Sang-Hwan Do
Postoperative urinary retention (POUR) is a common complication after total knee arthroplasty. Currently, there are no clinical data regarding the effects of magnesium sulfate on POUR. Here, we investigated the effects of intraoperative magnesium sulfate infusion in patients with POUR following total knee arthroplasty. We reviewed the medical records of patients who underwent elective unilateral total knee arthroplasty under spinal anesthesia between June 2016 and May 2018. The patients were grouped based on whether they were treated with magnesium (magnesium group) or not (control group). We investigated the incidence of POUR and the postoperative analgesic requirement. Totally, 483 patients were included in the analysis. After propensity score matching with the control group, the magnesium group showed a lower incidence of POUR (odds ratio, 0.49; 95% CI, 0.29–0.83; p = 0.011) and lesser opioid consumption (p = 0.049) than the control group. Multivariate logistic regression analysis revealed that intraoperative continuous infusion of magnesium (p = 0.008) and age (p = 0.001) were significantly related to the incidence of POUR. This retrospective observational study demonstrated that administration of magnesium sulfate was associated with a lower incidence of POUR following total knee arthroplasty.

23 December 2025 in Pain Medicine
Verified
Journal Article
Closed access
JLJoon Hee Lee
Joon Hee Lee
MCMinhye Chang
Minhye Chang
DLDongsik Lim
Dongsik Lim
FNFrancis Nahm
Francis Nahm
PLPyung-Bok Lee
Pyung-Bok Lee
ECEun Joo Choi
Eun Joo Choi
Background: Cancer-related pain management remains challenging, particularly for spinal metastases, in which pain arises from multiple pathological mechanisms. Despite the increasing use of epidural steroid injections (ESI) in clinical practice as part of multimodal pain management, the evidence of their effectiveness in these patients remains limited. Design: A retrospective cohort study. Setting: Three university-affiliated tertiary hospitals in South Korea. Subjects: A total of 123 patients with cancer and radiologically confirmed spinal metastases who underwent ESI between January 2020 and December 2022. Patients were categorized as effective (Group E, ≥50% pain reduction at 1 month, n = 73) or non-effective (Group N, n = 50). Methods: Pain intensity, opioid use, patient satisfaction, repeat procedures, and survival were evaluated at baseline and 1 and 3 months after ESI. In addition, factors influencing the effectiveness of ESI were analyzed. Results: A better performance status (ECOG-PS 1) and lower baseline opioid requirements predicted a favorable ESI response. The Group E maintained pain relief at 3 months with a minimal increase in opioid use, reported higher satisfaction (94.5% vs 6.5%), needed fewer repeat injections (64.4% vs 86.6%), and demonstrated better 6-month survival (78.1% vs 34.0%) than Group N. Conclusion: ESI may be beneficial in reducing pain and attenuating opioid escalation in patients with spinal metastases, especially when the performance status is relatively preserved, and before the initiation of high-dose opioid therapy. These results support early integration of ESI into multimodal cancer pain management strategies.

10 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DLDongsik Lim
Dongsik Lim
ECEun Joo Choi
Eun Joo Choi
FNFrancis Nahm
Francis Nahm
PLPyung-Bok Lee
Pyung-Bok Lee
Background /Objectives: Treatment response after percutaneous epidural neuroplasty (PEN) is heterogeneous. We evaluated clinical, imaging, and procedural factors associated with response after retrodiscal percutaneous epidural neuroplasty (RD-PEN). Methods: This retrospective, single-center observational study included 100 RD-PEN treatment episodes with evaluable 3-month outcomes. Composite response was defined as a ≥50% or ≥4-point reduction in Numeric Rating Scale (NRS) score, or a ≥30% or ≥2-point reduction with documented improvement in walking capacity. Eight candidate variables were entered into the initial multivariable logistic model, followed by backward likelihood-ratio elimination. The 6-month composite response was a secondary outcome, and NRS-only responses at 3 and 6 months were sensitivity outcomes. Results: At 3 months, 42 of 100 episodes responded. Prior lumbar surgery (adjusted odds ratio [OR], 0.23; 95% confidence interval [CI], 0.08–0.68; p = 0.008) and moderate-to-severe central canal stenosis (OR, 0.29; 95% CI, 0.11–0.76; p = 0.012) were associated with lower response odds, whereas a left-sided procedure was associated with higher odds (OR, 2.95; 95% CI, 1.20–7.23; p = 0.018). Shorter pain duration (<12 months) showed an imprecise association with higher response odds (OR, 3.40; 95% CI, 0.87–13.38; p = 0.079). Among 84 evaluable episodes at 6 months, prior surgery remained associated with lower response odds; NRS-only estimates were directionally similar. Intradiscal contrast spread occurred in 6 of 184 fluoroscopy-evaluable procedures (3.3%). Conclusions: Prior lumbar surgery and moderate-to-severe central canal stenosis were associated with lower 3-month response odds after RD-PEN, whereas a left-sided procedure was associated with higher odds. The laterality association did not reach statistical significance in the 6-month composite or NRS-only analyses and remained exploratory and potentially setting-specific.